Skip to main content

Development and validation of an HPLC method for simultaneous determination of trimethoprim and sulfamethoxazole in human plasma

Abstract

The combination of trimethoprim (TMP) and sulfamethoxazole (SMX) is used in the treatment of many common infections such as urinary, respiratory and gastrointestinal tract infections. The aim of this study was to determine TMP and SMX simultaneously in human plasma samples by high performance liquid chromatography (HPLC) using antipyrine as the internal standard. Separation of the compounds was achieved on a reverse-phase C8 column packed with 5 μm dimethyl octadecylsilyl bonded amorphous silica (4.6 mm × 250 mm) column using a mobile phase consisted of potassium hydrogen phosphate, acetonitrile, methanol and water adjusted to pH 6.2. The mobile phase was delivered at a flow rate of 1 mL min−1 and the effluent was monitored using Max plot technique at 25°C. Retention times were 5 min for TMP, 7 min for antipyrine and 9 min for SMX. Quantitation limits were 10 ng mL−1 for TMP and 50 ng mL−1 for SMX. Our findings indicated that the developed HPLC method was precise, accurate, specific and sensitive for simultaneous determination of TMP and SMX. Proposed HPLC method was successfully applied for the analysis of TMP and SMX in human plasma after oral administration of a co-trimoxazole tablet to human volunteers.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  • Akay C, Ozkan SA (2002) Simultaneous LC determination of trimethoprim and sulphamethoxazole in pharmaceutical formulations. J Pharm Biomed Anal 30:1207–1213

    Article  PubMed  CAS  Google Scholar 

  • Amini H, Ahmadiani A (2007) Rapid and simultaneous determination of sulfamethoxazole and trimethoprim in human plasma by high-performance liquid chromatography. J Pharm Biomed Anal 43:1146–1150

    Article  PubMed  CAS  Google Scholar 

  • Bedor DC, Gonçalves TM, Ferreira ML, de Sousa CE, Menezes AL, Oliveira EJ, de Santana DP (2008) Simultaneous determination of sulfamethoxazole and trimethoprim in biological fluids for high-throughput analysis: comparison of HPLC with ultraviolet and tandem mass spectrometric detection. J Chromatogr B Analyt Technol Biomed Life Sci 863:46–54

    Article  PubMed  CAS  Google Scholar 

  • Bioanalytical Method Validation (2001) U.S. Department of Health and Human Services Food and Drug Administration, CDER, CVM, May 2001. http://www.fda.gov/CDER/GUIDANCE/4252fnl.pdf

  • Bury RW, Mashford ML (1979) Analysis of trimethoprim and sulphamethoxazole in human plasma by high-pressure liquid chromatography. J Chromatogr 163:114–117

    Article  PubMed  CAS  Google Scholar 

  • DeAngelis DV, Woolley JL, Sigel CW (1990) High-performance liquid chromatographic assay for the simultaneous measurement of trimethoprim and sulfamethoxazole in plasma or urine. Ther Drug Monit 12:382–392

    Article  PubMed  CAS  Google Scholar 

  • Laizure SC, Holden CL, Stevens RC (1990) Ion-paired high-performance liquid chromatographic separation of trimethoprim, sulfamethoxazole and N4-acetylsulfamethoxazole with solid-phase extraction. J Chromatogr 528:235–242

    Article  PubMed  CAS  Google Scholar 

  • Martindale (2002) The complete drug reference, 33rd edn. In: Sweetman SC (ed). Pharmaceutical Press, London

  • Patel RB, Welling PG (1980) Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole). Clin Pharmacokinet 5:405–423

    Article  PubMed  CAS  Google Scholar 

  • Pereira A, Cass QB (2005) High-performance liquid chromatography method for the simultaneous determination of sulfamethoxazole and trimethoprim in bovine milk using an on-line clean-up column. J Chromatogr B Analyt Technol Biomed Life Sci 826:139–146

    Article  PubMed  CAS  Google Scholar 

  • Petri WA Jr. (2006) Sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections, Chap. 43. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman’s the pharmacological basis of therapeutics, 8th edn. The McGraw-Hill, New York

  • Q2B Validation of Analytical Procedures: Methodology (1996) U.S. Department of Health and Human Services Food and Drug Administration, CDER, CBER, November 1996. http://www.fda.gov/Cder/Guidance/1320fnl.pdf

  • Ronn AM, Mutabingwa TK, Kreisby S, Angelo HR, Fuursted K, Bygbjerg IC (1999) A reversed-phase high-performance liquid chromatography method for the determination of cotrimoxazole (trimethoprim/sulphamethoxazole) in children treated for malaria. Ther Drug Monit 21:609–614

    Article  PubMed  CAS  Google Scholar 

  • Spreux-Varoquaux O, Chapalain JP, Cordonnier P, Advenier C, Pays M, Lamine L (1983) Determination of trimethoprim, sulphamethoxazole and its N4-acetyl metabolite in biological fluids by high-performance liquid chromatography. J Chromatogr 274:187–199

    Article  PubMed  CAS  Google Scholar 

  • van der Steuijt K, Sonneveld P (1987) Concurrent analysis of methotrexate, trimethoprim, sulphamethoxazole and their major metabolites in plasma by high-performance liquid chromatography. J Chromatogr 422:328–333

    Article  PubMed  Google Scholar 

  • Vree TB, Hekster YA, Baars AM, Damsma JE, Kleijin EV (1978) Determination of trimethoprim and sulfamethoxazole (co-trimoxazole) in body fluids of man by means of high-performance liquid chromatography. J Chromatogr 146:103–112

    Article  PubMed  CAS  Google Scholar 

  • Weber A, Opheim KE, Siber GR, Ericson JF, Smith AL (1983) High-performance liquid chromatographic quantitation of trimethoprim, sulfamethoxazole, and N4-acetylsulfamethoxazole in body fluids. J Chromatogr 278:337–345

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Selma Sahin.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sayar, E., Sahin, S., Cevheroglu, S. et al. Development and validation of an HPLC method for simultaneous determination of trimethoprim and sulfamethoxazole in human plasma. Eur J Drug Metab Pharmacokinet 35, 41–46 (2010). https://doi.org/10.1007/s13318-010-0006-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13318-010-0006-9

Keywords

  • Antipyrine
  • HPLC
  • Sulfamethoxazole
  • Trimethoprim
  • Co-trimoxazole